To support patients with breast cancer, psychiatrists should be aware of possible medication interactions, psychiatric or neurologic adverse effects of treatment, and signs of disease progression--issues that are the focus here.
Rachel Lynn, MD
Advertisement
Articles by Rachel Lynn, MD
Advertisement
Latest Updated Articles
Breast Cancer: What Psychiatrists Need to KnowPublished: June 24th 2016 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
New Data on Lumateperone for Prevention of Relapse in Schizophrenia
3
Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP
4
Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder
5
